◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DGX

Quest Diagnostics Incorporated (DGX) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Services · DATA UPDATED 2026-09-18

Quest Diagnostics Incorporated (DGX) operates in the Health Care Services industry and is headquartered in Secaucus, United States with about 46,000 employees. Its market capitalization is roughly $27 billion. In the fiscal year ended 2025-12-31, DGX reported $11.0B in revenue and $992M in net income.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Interactive charts & full statements → Open the DGX valuation workbench →

DGX Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$11.6B	$11.0B	$9.9B	$9.3B	$9.9B	$10.8B	$9.4B	$7.7B	$7.5B	$7.7B	$7.5B	$7.5B	$7.4B	$7.1B	$7.4B	$7.5B	$7.4B	$7.5B	$7.2B	$6.7B	$6.3B
Gross Profit	$3.8B	$3.5B	$3.2B	$3.1B	$3.4B	$4.2B	$3.6B	$2.7B	$2.6B	$3.0B	$2.9B	$2.8B	$2.8B	$2.8B	$3.0B	$3.1B	$3.1B	$3.1B	$3.0B	$2.7B	$2.6B
Gross Margin %	33.1%	31.9%	32.9%	33.0%	34.7%	39.0%	38.5%	34.8%	34.6%	38.8%	38.6%	37.9%	37.6%	39.5%	40.9%	41.5%	41.4%	42.0%	41.3%	40.8%	41.0%
Operating Income (EBIT)	$1.6B	$1.6B	$1.3B	$1.3B	$1.4B	$2.4B	$2.0B	$1.2B	$1.1B	$1.2B	$1.3B	$1.4B	$983M	$1.5B	$1.2B	$995M	$1.3B	$1.4B	$1.2B	$1.1B	$1.1B
Operating Margin %	14.1%	14.5%	13.6%	13.6%	14.4%	22.1%	20.9%	15.9%	14.6%	15.1%	17.0%	18.7%	13.2%	20.6%	16.3%	13.2%	17.6%	18.2%	16.9%	16.3%	18.0%
Net Income	$1.1B	$992M	$871M	$854M	$946M	$2.0B	$1.4B	$858M	$736M	$772M	$645M	$709M	$556M	$849M	$556M	$471M	$721M	$729M	$582M	$340M	$586M
Net Margin %	9.2%	9.0%	8.8%	9.2%	9.6%	18.5%	15.2%	11.1%	9.8%	10.0%	8.6%	9.5%	7.5%	11.9%	7.5%	6.3%	9.8%	9.8%	8.0%	5.1%	9.3%
EBITDA	$2.0B	$2.2B	$1.9B	$1.3B	$1.8B	$3.2B	$2.4B	$1.6B	$1.4B	$1.5B	$1.5B	$1.6B	$1.3B	$1.8B	$1.5B	$1.3B	$1.6B	$1.6B	$1.5B	$1.3B	$1.3B
Earnings Per Share (EPS)	$9.46	$8.78	$7.71	$7.56	$8.02	$15.59	$10.52	$6.31	$5.29	$5.51	$4.54	$4.89	$3.83	$5.55	$3.47	$2.94	$4.07	$3.88	$2.97	$1.74	$2.94
Shares Outstanding (M)	112M	113M	113M	113M	118M	128M	136M	136M	139M	140M	142M	145M	145M	153M	160M	160M	177M	188M	196M	195M	200M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DGX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$3.0B	$2.9B	$2.8B	$2.8B	$2.8B	$2.7B	$2.6B	$2.5B
Gross Profit	$1.0B	$942M	$914M	$949M	$943M	$863M	$858M	$811M
Gross Margin %	33.8%	32.5%	32.6%	33.7%	34.2%	32.5%	32.7%	32.6%
Operating Income (EBIT)	$459M	$399M	$391M	$386M	$438M	$346M	$361M	$330M
Operating Margin %	15.1%	13.8%	13.9%	13.7%	15.9%	13.1%	13.8%	13.3%
Net Income	$320M	$252M	$245M	$245M	$282M	$220M	$222M	$226M
Net Margin %	10.5%	8.7%	8.7%	8.7%	10.2%	8.3%	8.5%	9.1%
EBITDA	$481M	$434M	$546M	$547M	$596M	$488M	$507M	$479M
Earnings Per Share (EPS)	$2.86	$2.25	$2.19	$2.17	$2.50	$1.95	$1.96	$2.00
Shares Outstanding (M)	112M	112M	112M	113M	113M	113M	113M	113M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DGX Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.8B	$1.9B	$1.3B	$1.3B	$1.7B	$2.2B	$2.0B	$1.2B	$1.2B	$1.2B	$1.1B	$810M	$938M	$652M	$1.2B	$896M	$1.1B	$997M	$1.1B	$927M	$952M
Capital Expenditures (CapEx)	$554M	$527M	$425M	$408M	$404M	$403M	$418M	$400M	$383M	$252M	$293M	$263M	$308M	$231M	$182M	$162M	$205M	$167M	$213M	$219M	$193M
Free Cash Flow (FCF)	$1.2B	$1.4B	$909M	$864M	$1.3B	$1.8B	$1.6B	$843M	$817M	$923M	$776M	$547M	$630M	$421M	$1.0B	$734M	$913M	$830M	$850M	$708M	$758M
FCF Margin %	10.5%	12.3%	9.2%	9.3%	13.3%	17.0%	16.8%	10.9%	10.8%	12.0%	10.3%	7.3%	8.5%	5.9%	13.6%	9.8%	12.4%	11.1%	11.7%	10.6%	12.1%
Dividends Paid	$363M	$353M	$331M	$314M	$305M	$309M	$297M	$286M	$266M	$247M	$223M	$212M	$187M	$185M	$108M	$65M	$108M	$110M	$78M	$77M	$77M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DGX Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$468M	$278M	$465M	$563M	$544M	$314M	$464M	$356M
Capital Expenditures (CapEx)	$138M	$114M	$158M	$144M	$108M	$117M	$123M	$106M
Free Cash Flow (FCF)	$330M	$164M	$307M	$419M	$436M	$197M	$341M	$250M
FCF Margin %	10.8%	5.7%	10.9%	14.9%	15.8%	7.4%	13.0%	10.1%
Dividends Paid	$96M	$88M	$90M	$89M	$90M	$84M	$84M	$84M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DGX Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$16.9B	$16.2B	$16.2B	$14.0B	$12.8B	$13.6B	$14.0B	$12.8B	$11.0B	$10.5B	$10.1B	$10.0B	$9.9B	$8.9B	$9.3B	$9.3B	$8.5B	$8.6B	$8.4B	$8.6B	$5.7B
Cash & Cash Equivalents	$626M	$420M	$549M	$686M	$315M	$872M	$1.2B	$1.2B	$135M	$137M	$359M	$133M	$192M	$187M	$296M	$165M	$449M	$534M	$254M	$168M	$150M
Total Liabilities	$9.1B	$8.9B	$9.3B	$7.6B	$6.8B	$7.0B	$7.1B	$7.1B	$5.7B	$5.5B	$5.4B	$5.2B	$5.5B	$5.0B	$5.1B	$5.6B	$4.5B	$4.6B	$4.8B	$5.2B	$2.6B
Total Debt (Short + Long-Term)	$5.8B	$5.8B	$6.6B	$5.0B	$4.2B	$4.3B	$4.3B	$5.0B	$4.0B	$3.9B	$3.7B	$3.7B	$3.8B	$3.3B	$3.4B	$4.0B	$3.0B	$3.1B	$3.1B	$3.5B	$1.6B
Total Shareholders' Equity	$7.5B	$7.2B	$6.8B	$6.3B	$5.9B	$6.4B	$6.8B	$5.6B	$5.2B	$4.9B	$4.6B	$4.7B	$4.3B	$3.9B	$4.2B	$3.7B	$4.0B	$4.0B	$3.6B	$3.3B	$3.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DGX viewer.

DGX Metric Deep Dives

Other Companies in Health Care Services

CVS · CVS Health — $114 billion
CI · Cigna — $73 billion
LH · Labcorp — $26 billion
DVA · DaVita — $12 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← DGT All “D” companies DGXU →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.